Wound healing carries some of the strongest randomized numbers in this field.
Chronic wounds, and diabetic foot ulcers above all, are where cell therapy research produces its most consequential endpoint: limbs. Multiple meta-analyses of randomized trials now report on healing rates and amputation, and the numbers deserve to be read carefully, in both directions.
Here is what they show, the certainty caveats that belong beside them, and why urgency changes everything in this category.
Aurenza does not claim that regenerative medicine treats, cures, or heals chronic wounds.
Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.
What the Research Shows
Chronic wounds, and diabetic foot ulcers above all, are where this research produces its most consequential endpoint: limbs. The randomized literature here is deep enough to pool many times over, and the numbers repeat across independent teams.
A 2023 meta-analysis of 19 randomized controlled trials covering 766 patients with diabetic foot ulcers found substantially higher healing odds with cell therapy, markedly lower amputation odds, and longer pain-free walking distance. A meta-analysis of eight randomized studies found an amputation relative risk of 0.25 and a wound healing relative risk of 2.05 in favor of cell therapy. An earlier seven-study meta-analysis covering 224 patients found partial or complete healing in 77.4% of cell-treated patients versus 31.9% of controls, and a pooled analysis of cellular therapy trials found better ankle-brachial index, transcutaneous oxygen pressure, healing rates, amputation-free survival, and pain scores.
The signal has held as the literature matured: a 2024 GRADE-compliant bootstrapped meta-analysis of randomized clinical trials again found cell therapy significantly superior to conventional approaches, and a 2026 pooled analysis of 32 randomized trials covering 2,059 patients now exists on ulcer healing and amputation outcomes.
The Honest Line
Numbers that strong deserve their caveats in the same breath. The underlying trials vary in cell type, dose, delivery, and wound severity, several are small, and certainty ratings across outcomes run from very low to moderate. A 2025 meta-analysis of six randomized trials found the healing benefit concentrated in smaller ulcers, with no significant benefit in large ulcers and no significant amputation difference in that particular analysis. So the fair summary is a consistent, repeated randomized signal that has not yet reached top-tier certainty. No study shows a guarantee it works every time, or that it will work for you, and every trial added cells to aggressive standard care, offloading, debridement, infection control, and vascular assessment, never in place of it. A wound that is infected, deep, or on a cold foot needs local care now, not a program with travel dates, and we will tell you so.
Why This Is Exactly Where a Candidacy Review Comes In
What standard care your wound is receiving today, what your circulation supports, and where your metabolic control sits decide everything here, and a review checks all three before any conversation goes further, in coordination with your wound care team. Every trial above produced its results in selected patients who met specific criteria. That is the gap between "documented in research" and "right for you," and it is the gap a candidacy review exists to close. Before anything is recommended, your bloodwork, biomarkers, imaging, and history are reviewed by a physician panel to establish whether you are actually in the population the research describes. If the picture supports moving forward, you will know exactly why. If it does not, you will be told that, plainly. That is where to start.
Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.
What Your Candidacy Review Covers
- The wound itself: duration, depth, infection status, and what standard care it is currently receiving.
- Your circulation, since arterial supply determines what any therapy can accomplish.
- Your metabolic control, the environment every diabetic wound sits in.
- Signs that need urgent local care first, which pause any candidacy conversation until addressed.
- Physician panel review, in coordination with your wound care providers.
What to Ask Any Provider
Is my wound currently getting proper standard care, and will that continue? Which trials are you citing, and do their wound types match mine? What is being administered, by what route, at what verified cell count? What findings would make this inappropriate or unsafe for me right now? How will healing be measured and by whom?
The Honest Limits
Individual results cannot be predicted or guaranteed. These applications are not FDA approved for wound care, and any coordinated procedure takes place in Mexico under COFEPRIS regulation. Worsening pain, spreading redness, odor, fever, or a cold or discolored foot are emergencies: seek local care immediately.
Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.
Free consultation with a care consultant, many of whom are registered nurses. No sales reps. No receptionist.